Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Hessen

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Neuropsychology|November 16, 2020
Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer's pathology and progression to dementiaIngvild Vøllo Eliassen, Tormod Fladby, Bjørn-Eivind Kirsebom, et al.
Applied Neuropsychology. Adult|May 10, 2021
Regression-based norms for the FAS phonemic fluency test for ages 40-84 based on a Norwegian sampleIngrid Myrvoll Lorentzen, Jacob Espenes, Erik Hessen, et al.
The Clinical Neuropsychologist|June 21, 2018
Training models and status of clinical neuropsychologists in Europe: Results of a survey on 30 countriesLaura Hokkanen, Sandra Lettner, Fernando Barbosa, et al.
NPJ Parkinson'S Disease|July 21, 2017
Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson's disease: a cross-sectional studyAne Løvli Stav, Krisztina Kunszt Johansen, Eirik Auning, et al.
Dementia and Geriatric Cognitive Disorders Extra|June 28, 2024
Depressive Symptoms Are Not Associated with Predementia Cerebrospinal Fluid Amyloid PathologyCecilia Magdalena Eriksson, Bjørn-Eivind Kirsebom, Ragna Espenes, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 1, 2017
Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sampleMarie Eckerström, Mattias Göthlin, Sindre Rolstad, et al.
Journal of Alzheimer'S Disease : JAD|January 8, 2019
In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI CriterionErik Hessen, Bjørn-Eivind Kirsebom, Cecilia Magdalena Eriksson, et al.
The Clinical Neuropsychologist|October 9, 2020
Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 yearsJacob Espenes, Erik Hessen, Ingvild Vøllo Eliassen, et al.
Applied Neuropsychology. Adult|August 8, 2023
Investigating the relationship between allocentric spatial working memory and biomarker status in preclinical and prodromal Alzheimer's diseaseIngrid Myrvoll Lorentzen, Jacob Espenes, Ingvild Vøllo Eliassen, et al.
Scientific Reports|October 14, 2021
Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depressionNikias Siafarikas, Bjørn-Eivind Kirsebom, Deepak P Srivastava, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Neuropsychology|November 16, 2020
Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer's pathology and progression to dementiaIngvild Vøllo Eliassen, Tormod Fladby, Bjørn-Eivind Kirsebom, et al.
Applied Neuropsychology. Adult|May 10, 2021
Regression-based norms for the FAS phonemic fluency test for ages 40-84 based on a Norwegian sampleIngrid Myrvoll Lorentzen, Jacob Espenes, Erik Hessen, et al.
The Clinical Neuropsychologist|June 21, 2018
Training models and status of clinical neuropsychologists in Europe: Results of a survey on 30 countriesLaura Hokkanen, Sandra Lettner, Fernando Barbosa, et al.
NPJ Parkinson'S Disease|July 21, 2017
Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson's disease: a cross-sectional studyAne Løvli Stav, Krisztina Kunszt Johansen, Eirik Auning, et al.
Dementia and Geriatric Cognitive Disorders Extra|June 28, 2024
Depressive Symptoms Are Not Associated with Predementia Cerebrospinal Fluid Amyloid PathologyCecilia Magdalena Eriksson, Bjørn-Eivind Kirsebom, Ragna Espenes, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 1, 2017
Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sampleMarie Eckerström, Mattias Göthlin, Sindre Rolstad, et al.
Journal of Alzheimer'S Disease : JAD|January 8, 2019
In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI CriterionErik Hessen, Bjørn-Eivind Kirsebom, Cecilia Magdalena Eriksson, et al.
The Clinical Neuropsychologist|October 9, 2020
Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 yearsJacob Espenes, Erik Hessen, Ingvild Vøllo Eliassen, et al.
Applied Neuropsychology. Adult|August 8, 2023
Investigating the relationship between allocentric spatial working memory and biomarker status in preclinical and prodromal Alzheimer's diseaseIngrid Myrvoll Lorentzen, Jacob Espenes, Ingvild Vøllo Eliassen, et al.
Scientific Reports|October 14, 2021
Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depressionNikias Siafarikas, Bjørn-Eivind Kirsebom, Deepak P Srivastava, et al.
Pageof 7